Plasma Kallikrein Inhibitor [EPC] - N0000192750

Pharmacologic Code	N0000192750
Pharmacologic Name	Plasma Kallikrein Inhibitor
Pharmacologic Uses	plasma kallikrein inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Plasma Kallikrein Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	47783-101	Kalbitor	Non-Proprietary Name: Ecallantide	Injection, Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	47783-644	Takhzyro	Non-Proprietary Name: Lanadelumab-flyo	Injection, Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	47783-645	Takhzyro	Non-Proprietary Name: Lanadelumab-flyo	Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	47783-646	Takhzyro	Non-Proprietary Name: Lanadelumab-flyo	Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE